Serum Institute, Bharat Biotech to begin trial of intranasal COVID ١٩ vaccine soon – minister

ما يقرب من ٥ سنوات فى nationalpost

NEW DELHI — Serum Institute of India and Bharat Biotech are expected to pursue late stage clinical trials of intranasal COVID-19 vaccines in the coming months once they receive regulatory approval, India’s health minister said on Sunday. Dr Harsh Vardhan said the late stage trial generally involves thousands of participants, sometimes 30,000 to 40,000. Of […]

ذكر فى هذا الخبر
شارك الخبر على